Inhibition of FSP1-MYH9 Interaction Reduces TGF-β-induced Podocyte Injury: Potential Therapeutic Role of Trifluoperazine
Research Journal of Critical Care Nephrology · 10.01.2026 · 2 (1) · 22-31
DOI: 10.66224/rjccn.2.01.37 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Journal of Critical Care Nephrology, online erschienen am 10.01.2026. Verfasst von Zhen Liu und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liu, Z., Li, H., Mukanhair, L., Wang, T., Zhang, X., Liu, G., Peng, H., & Ren, X. (2026). Inhibition of FSP1-MYH9 Interaction Reduces TGF-β-induced Podocyte Injury: Potential Therapeutic Role of Trifluoperazine. Research Journal of Critical Care Nephrology, 2(1), 22-31. https://doi.org/10.66224/rjccn.2.01.37
Vancouver
Liu Z, Li H, Mukanhair L, Wang T, Zhang X, Liu G, et al. Inhibition of FSP1-MYH9 Interaction Reduces TGF-β-induced Podocyte Injury: Potential Therapeutic Role of Trifluoperazine. Research Journal of Critical Care Nephrology. 2026;2(1):22-31. doi:10.66224/rjccn.2.01.37
BibTeX
@article{Liu2026,
author = {Liu, Zhen and Li, Hongye and Mukanhair, Lydia and Wang, Ting and Zhang, Xiaotian and Liu, Guangling and Peng, Hongjun and Ren, Xianguo},
title = {Inhibition of FSP1-MYH9 Interaction Reduces TGF-β-induced Podocyte Injury: Potential Therapeutic Role of Trifluoperazine},
journal = {Research Journal of Critical Care Nephrology},
year = {2026},
volume = {2},
number = {1},
pages = {22--31},
doi = {10.66224/rjccn.2.01.37}
}
EUVIMED